| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.32B | +44.2% |
| R&D Expense | $20.9M | -9.7% |
| SG&A Expense | $189.2M | -27.0% |
| Operating Income | -$662.2M | +0.6% |
| Pre-tax Income | -$847.4M | +12.8% |
| Income Tax | $2.3M | -75.3% |
| Net Income | $173.4M | +318.3% |
| EPS (Basic) | $0.82 | +310.3% |
| EPS (Diluted) | $0.80 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $214.3M | +46.7% |
| Inventory | $783.9M | +54.7% |
| Current Assets | $2.10B | +35.5% |
| Total Assets | $19.27B | +16.9% |
| Current Liabilities | $1.16B | +14.2% |
| Long-term Debt | $8.40B | +29.2% |
| Total Liabilities | $11.09B | +24.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$848.8M | -3.9% |
| Capital Expenditures | $18.2M | +112.3% |
| Investing Cash Flow | -$2.09B | -23.7% |
| Financing Cash Flow | $3.04B | +14.8% |
| Free Cash Flow | -$867.0M | -5.0% |
| +305.1% |
| Stockholders' Equity |
| $6.71B |
| +7.2% |